Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › TNXP

SUPERSTRING CAPITAL MANAGEMENT LP position in TNXP

TONIX PHARMACEUTICALS HL · Health Care

SUPERSTRING CAPITAL MANAGEMENT LP reported holding 63,648 shares of TNXP (TONIX PHARMACEUTICALS HL) in its Q2 2026 13F filing — a position valued at US$812K, representing 0.51% of its reported portfolio and ranking #27 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed TNXP holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)63.65K sh
Reported value held$812.15K
Portfolio Weight0.51%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SUPERSTRING CAPITAL MANAGEMENT LP's TNXP position evolved

SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in TNXP in Q1 2026 at 63,540 shares (US$874K). Across 2 filings, SUPERSTRING CAPITAL MANAGEMENT LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 63,648 shares valued at US$812K.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 63.54K $873.67K New
Q2 2026 63.65K $812.15K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TNXP and 13F data

TNXP (TONIX PHARMACEUTICALS HL) is a Health Care company. 69 other funds we track also report a position in TNXP — the largest reported positions include Jones Hill Capital LP (US$8.0M), Ishara Investments LP (US$4.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TNXP

All TNXP fund holders →

FAQ

How long has SUPERSTRING CAPITAL MANAGEMENT LP held TNXP?

SUPERSTRING CAPITAL MANAGEMENT LP has disclosed TNXP holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in TNXP?

As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 63.65K shares of TNXP (TONIX PHARMACEUTICALS HL), valued at $812.15K, representing 0.51% of its reported portfolio and ranking #27.

Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling TNXP?

In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP held unchanged its position in TNXP.

Which other funds hold TNXP?

Other major institutional holders of TNXP include Jones Hill Capital LP, Ishara Investments LP, among 69 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.